Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Algorithm for Bipolar Depression Treatment in Brazilian Public Healthcare
NCT02918097Phase 4Completed
- Sponsor
- Universidade Federal do Rio Grande do Sul
- Start
- May 2010
- Primary completion
- Nov 2014
- Modality
- DNA Intercalators/Alkylators
01
Overview
Phase 4, randomised, open-label trial of lithium carbonate, sertraline, nortriptyline and risperidone in bipolar disorder (BD), sponsored by Universidade Federal do Rio Grande do Sul. Primary endpoints: Number of Participants With Response to Treatment at 8 weeks and Quality of Life Instrument Scores at 12 weeks. Started May 2010; status: completed.
02
Drugs
lithium carbonatesertralinenortriptylinerisperidone
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT02918097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02918097.